Xbiome Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B2

  • Investors
  • 9

Xbiome General Information


Developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Primary Office
  • Room 907, 9th Floor, Scientific Research Building
  • Tsinghua Information Port, Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xbiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B2) 22-Dec-2021 000.00 Completed Generating Revenue
4. Early Stage VC (Series B1) 27-Nov-2020 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 04-Nov-2019 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A1) 01-Jan-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Aug-2018 Completed Generating Revenue
To view Xbiome’s complete valuation and funding history, request access »

Xbiome Comparisons

HQ Location
Total Raised
Post Valuation
Developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. The company uses artifici
Shenzhen, China
00000000000 000.00


t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000 000000000
Cambridge, MA
000 As of 0000
0000 0000-00-00
00000000000 00000


lore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
Cambridge, MA
000 As of 0000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xbiome Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000000 00000000 Venture Capital-Backed Hong Kong, Hong Kong 000 00000 00000000 00000
000000 000000 Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
To view Xbiome’s complete competitors history, request access »

Xbiome Patents

Xbiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220073996-A1 Model for predicting treatment responsiveness based on intestinal microbial information Pending 22-Jan-2019 000000000

Xbiome Executive Team (1)

Name Title Board Seat Contact Info
Yan Tan Ph.D Co-Founder & Chief Executive Officer
To view Xbiome’s complete executive team members history, request access »

Xbiome Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hike Capital Venture Capital Minority 000 0000 000000 0
Tiantu Capital Venture Capital Minority 000 0000 000000 0
Primavera Capital Group Growth/Expansion Minority 000 0000 000000 0
Sky9 Capital Venture Capital Minority 000 0000 000000 0
YiMei Capital Management Fund of Funds Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Xbiome Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Assembly Biosciences (M201 Program) 25-Apr-2022 000000000 Buildings and Property 000 000 0
To view Xbiome’s complete investments history, request access »